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type 2 diabetes into clinical trials at three United States institutions, we reviewed recruitment and
retention strategies in clinical trials of youth with various chronic conditions. We explored
whether similar strategies might be applicable to pediatric patients with type 2 diabetes.
Methods: We compiled data on recruitment and retention of adolescents with type 2 diabetes at
three centers (National Institutes of Health, Bethesda, Maryland; Baylor College of Medicine,
Houston, Texas; and Children’s National Medical Center, Washington, DC) from January 2009 to
December 2011. We also conducted a thorough literature review on recruitment and retention in
adolescents with chronic health conditions.
Results: The number of recruited patients was inadequate for timely completion of ongoing trials.
Our review of recruitment strategies in adolescents included monetary and material incentives,
technology-based advertising, word-of-mouth referral, and continuous patienteresearch team
contact. Cellular or Internet technology appeared promising in improving participation among
youths in studies of various chronic conditions and social behaviors.
Conclusions: Adolescents with type 2 diabetes are particularly difﬁcult to engage in clinical trials.
Monetary incentives and use of technology do not represent “magic bullets,” but may presently be
the most effective tools. Future studies should be conducted to explore motivation in this popu-
lation. We speculate that (1) recruitment into interventional trials that address the main concerns
of the affected youth (e.g., weight loss, body image, and stress management) combined with less
tangible outcomes (e.g., blood glucose control) may be more successful; and (2) study participation
and retention may be improved by accommodating patients’ and caregivers’ schedules, by
scheduling study visits before and after working hours, and in more convenient locations than in
medical facilities.
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Compliance with medica-
tions and doctor’s ap-
pointments is suboptimal
in youth with type 2 dia-
betes. Additional chal-
lenges speciﬁc to clinical
research add to the gener-
ally observed difﬁcult
recruitment into clinical
trials. Better understand-
ing of effective recruitment
strategies of adolescents
with other chronic condi-
tionsmay guide our efforts,
but changes to conven-
tionalapproachesinclinical
research appear necessary.Over the past 3 decades, type 2 diabetes has become
increasingly prevalent in children. Yet, the only Food and Drug
Administrationeapproved treatments of youths (<18 years of
age) are metformin and insulin. Furthermore, lifestyle changes
and combination therapy of metformin with rosiglitazone haveD license.
T.T. Nguyen et al. / Journal of Adolescent Health 54 (2014) 247e254248shown little improvement beyond standard therapy, as recently
demonstrated by the Treatment Options for Type 2 Diabetes in
Adolescents and Youth (TODAY) trial, a large multicenter study
evaluating the effectiveness of three different treatment arms
(lifestyle, metformin alone, and metformin with rosiglitazone)
for blood glucose control [1,2]. Thus, more studies are needed but
are hampered by the difﬁculty of recruiting children with type 2
diabetes. Current recruitment methods have not been effective in
children and adolescents with type 2 diabetes or at risk for it
[1e4]. Here, we report the collective experience of three large
United States (U.S.) medical centers and discuss various recruit-
ment strategies in clinical trials enrolling adolescents and young
adults.
Reasons for slow recruitmentof youthswith type 2 diabetes are
manifold, including the perception of invulnerability [5], few
clinical symptoms except at diagnosis, and time restraints because
of school, part-time jobs, and other responsibilities [4]. The
recruitment of minority youths, speciﬁcally those from low-
income backgrounds, is especially challenging because traditional
recruitment strategies may not work for these individuals [6e8].
Further reasons for slow recruitment come to light when
comparing pediatric type 2 diabetes and type 1 diabetes. Chil-
dren and adolescents with type 1 diabetes have participated in
clinical trials without comparable difﬁculties for the past
70 years [9]. However, their socioeconomic status is generally
higher [10e12], parental involvement is greater, and in case of
noncompliance with insulin treatment, symptoms occur rapidly.
In comparison, patients with type 2 diabetes often belong to
less afﬂuent socioeconomic strata [13]. Racial demographics
differ markedly; predominantly African-American and Hispanic
adolescents develop type 2 diabetes, many of whom struggle
with poverty and little or no access to health care [10e12,14].
Adults from these families often have type 2 diabetes as well, and
may not have the means, time, or education to obtain adequate
care. In addition, patients with type 1 diabetes may more easily
recognize beneﬁts from participation in clinical trials (e.g., pre-
vention of hypoglycemia, lowering of insulin doses), whereas
adolescents with type 2 diabetes, who frequently identify obesity
rather than diabetes as their most important health issue, may
perceive negative effects from clinical interventions (e.g., weight
gain due to insulin treatment).
Traditional recruitment strategies in adolescents typically
entail advertising with colorful, eye-catching ﬂyers and letters to
potential participants, their parents, and their physicians.
Although such initiatives spark some initial interest they are
usually insufﬁcient to lead to effective recruitment [3,4,15e21].
Thus, more patient-friendly approaches are needed. For example,
the Oklahoma site of the TODAY trial provided transportation
and home visits for follow-up appointments. Similarly, the
TeeneLongitudinal Assessment of Bariatric Surgery study ach-
ieved sustained patient retention with in-home follow-up visits
for patients unable to attend clinic appointments [22,23]. Here,
we further explore potential approaches to improve recruitment
and retention of youth with type 2 diabetes, by reviewing our
experience at three U.S. sites and the published literature on
adolescent recruitment.
Methods
We compiled data on new diagnoses of type 2 diabetes, the
number of outpatient visits, and recruitment and retention re-
sults from three centers (National Institutes of Health (NIH),Bethesda, Maryland; Baylor College of Medicine, Houston, Texas;
and Children’s National Medical Center, Washington, DC) from
January 2009 to December 2011. The latter two centers function
as primary care facilities, whereas NIH is a referral-based clinical
research facility.
We also reviewed strategies for recruitment and retention
used in adolescents and young adults with chronic conditions by
conducting a literature search in PubMed and EMBASE from the
year 2000 to present. Search terms included: type 2 diabetes,
diabetes mellitus, diabetes, recruitment, retention, strategies,
clinical trials, adolescence, adolescents, pediatric, and youth. To
be considered studies had to (1) be published in the English
language in a peer-reviewed journal after 2000; (2) include
subjects 12e25 years of age; (3) address recruitment and
retention strategies in clinical trials of adolescents and young
adults with chronic illnesses and/or high-risk social and health
behaviors; and (4) contain original data. From this original pool,
we selected those potentially applicable to type 2 diabetes based
on our experience. We paid particular attention to strategies that
were unique and innovative, and promised to appeal to the in-
terests of the target group.
From each article we extracted information on authors, study
location and duration, intervention, demographic characteristics
(age, gender, race/ethnicity, and diagnosis), site of recruitment,
and number of patients recruited and retained.
Results
Recruitment of youth with type 2 diabetes at three United States
sites
Between January 2009 and December 2011, over 400 new
diagnoses of type 2 diabetes in young individuals were recorded
at the National Children’s Hospital in Washington, DC, and Texas
Children’s Hospital (Baylor College of Medicine) in Houston,
Texas; of these 400 patients, fewer than 60 were recruited into
various clinical trials (Table 1). The NIH in Bethesda, Maryland,
depends on patients referred or self-referred for participation in
clinical research protocols. Over the 2-year observation period,11
new patients were recruited and enrolled, of whom two partic-
ipated in two type 2 diabetes related trials (Short-Term Beta Cell
Rest [NCT00445627] and Partners for Better Health: The Buddy
Study [NCT NCT01007266]).
Applicable recruitment strategies (incentivesandadvertisement). We
identiﬁed a total of 126 articles, 70 of which applied to adoles-
cents or young adults within the age range of 12e25 years. A
total of 31 articles fulﬁlled all inclusion criteria (Figure 1).
Table 2 lists details about the clinical trials and the applied
recruitment strategies. Monetary incentives were the most
common means of engaging adolescents, particularly in
research involving chronic conditions such as hypertension, for
which patients and families may not be actively seeking med-
ical care [3,4,15e21,24e32]. In studies with school-based
recruitment sites, monetary awards were one of the strongest
motivating factors [3,27]. In addition, parents enrolling their
children in health behavior studies recalled that a free physical
health screening at school, followed by a thorough explanation
of their child’s health status, was another key incentive [3].
With the continuous change in social communication among
youth, researchers have adapted their recruitment approaches
to attract the attention of an extremely technology-savvy
Ta
b
le
1
Re
cr
u
it
m
en
t
n
u
m
be
rs
fo
r
p
ed
ia
tr
ic
ty
p
e
2
d
ia
be
te
s
at
th
re
e
cl
in
ic
al
re
se
ar
ch
ce
n
te
rs
C
en
te
r
n
am
e
N
ew
T2
D
M
d
ia
gn
os
es
(<
25
Y
ea
rs
of
ag
e)
p
er
ye
ar
,n
O
u
tp
at
ie
n
t
T2
D
M
cl
in
ic
vi
si
ts
p
er
ye
ar
,n
Ti
tl
e
of
cl
in
ic
al
re
se
ar
ch
st
u
d
y
St
u
d
y
st
ar
t
d
at
e
Pa
ti
en
ts
n
ee
d
ed
to
co
m
p
le
te
st
u
d
y,
n
Pa
ti
en
ts
re
cr
u
it
ed
si
n
ce
st
ar
t,
n
Pa
ti
en
ts
lo
st
to
fo
llo
w
-u
p
,n
R
ec
ru
it
m
en
t
go
al
m
et
,%
C
h
ild
re
n
’s
N
at
io
n
al
M
ed
ic
al
C
en
te
r
(W
as
h
in
gt
on
,D
C
)
42
(2
00
9)
83
(2
01
0)
92
(2
01
1)
31
5
(2
00
9)
39
7
(2
01
0)
30
6
(2
01
1)
Pa
rt
n
er
s
fo
r
B
et
te
r
H
ea
lt
h
in
A
d
ol
es
ce
n
t
Ty
p
e
2
D
ia
be
te
s:
Th
e
B
u
d
d
y
St
u
d
y
20
09
60
10
4
6.
7
N
at
io
n
al
In
st
it
u
te
s
of
H
ea
lt
h
(B
et
h
es
d
a,
M
ar
yl
an
d
)
N
/A
N
/A
Ef
fe
ct
of
Sh
or
t-
Te
rm
B
et
a
C
el
lR
es
t
in
A
d
ol
es
ce
n
ts
an
d
Y
ou
n
g
A
d
u
lt
s
W
it
h
Ty
p
e
2
D
ia
be
te
s
M
el
lit
u
s
20
07
75
11
5
14
.7
Pa
rt
n
er
s
fo
r
B
et
te
r
H
ea
lt
h
in
A
d
ol
es
ce
n
t
Ty
p
e
2
D
ia
be
te
s:
Th
e
B
u
d
d
y
St
u
d
y
20
09
60
2
0
3.
3
Te
xa
s
C
h
ild
re
n
’s
H
os
p
it
al
e
B
ay
lo
r
C
ol
le
ge
of
M
ed
ic
in
e
(H
ou
st
on
,
Te
xa
s)
65
(2
00
9)
74
(2
01
0)
54
(2
01
1)
60
9
(2
00
9)
61
0
(2
01
0)
59
5
(2
01
1)
Th
e
R
ol
e
of
A
m
yl
in
an
d
In
cr
et
in
s
on
Po
st
p
ra
n
d
ia
l
M
et
ab
ol
is
m
s
in
A
d
ol
es
ce
n
ts
W
it
h
T2
D
M
20
05
20
13
1
65
.0
Th
e
Ef
fe
ct
of
B
ye
tt
a
an
d
Sy
m
lin
on
Po
st
-m
ea
l
M
ea
l
B
lo
od
Su
ga
r
Le
ve
ls
in
C
h
ild
re
n
W
it
h
T2
D
M
20
09
16
10
1
62
.5
C
ol
es
ev
el
am
Pe
d
ia
tr
ic
T2
D
M
St
u
d
y
(W
EL
K
id
D
M
)
20
10
20
0
7
1
3.
5
G
lu
co
se
Pr
od
u
ct
io
n
an
d
G
lu
co
n
eo
ge
n
es
is
in
C
h
ild
re
n
W
it
h
T2
D
M
20
11
28
7
1
25
.0
N
/A
¼
n
ot
ap
p
lic
ab
le
;
T2
D
M
¼
ty
p
e
2
d
ia
be
te
s
m
el
lit
u
s.
T.T. Nguyen et al. / Journal of Adolescent Health 54 (2014) 247e254 249adolescent population [33,34]. Many pediatric research groups
have implemented technology-based incentivesdprimarily
prepaid mobile phonesdto attract study participants
[19,25,28]. A British group explored the use of a text messaging
system in the management of patients with type 1 diabetes
between clinic visits. Participants received a pay-as-you-go
mobile phone for the duration of the study and a £10
(approximately $15 in 2002 U.S. dollars) phone card, all of
which could be put toward personal use, whereas messages to
the research team were free of charge [25]. Participation
improved, likely because communicating with text messaging
required minimal time commitment (<1 minute to send a text
message to the diabetes management system) and offered
them free mobile phone use [19]. In another example, re-
searchers investigating youth alcohol consumption found that
combining texting technology with colloquial or slang-based
language (“Y R U drinking/going 2 drink 2 night?”) appealed
to their participants and encouraged more precise answers
because language formalities were no longer a concern [28].
A few clinical groups turned to online advertising on social
networking sites. These ads have used ﬂashy recruitment ban-
ners on websites heavily trafﬁcked by adolescents and young
adults. For one group, targeted advertising on Yahoo! resulted
in increasedwebsite trafﬁc and successful recruitment numbers
[15]. With the current popularity of Facebook (in 2011, it was
the most popular website on the World Wide Web), some re-
searchers have used this means of social networking: for
example, in a clinical trial designed to increase moderate to
vigorous physical activity in middle school girls [35].
A group working with young adult injection drug users
enlisted their enrollees to participate in peer-to-peer adver-
tising. The group established a coupon-based strategy that
allotted three recruitment coupons (each labeled with a unique
serial number for tracking purposes) to participants who had
successfully completed the baseline interviews, so that they
could pass the coupons on to other young injection drug users.
If any of the three new recruits appeared for screening visits and
met eligibility criteria, the original injection drug user would be
compensated for his or her effort [18].
In another example, the Western Australia Department of
Health’s 2005 chlamydia campaign used text message adver-
tising to communicate sexual health information to teens. In
post-campaign surveys, participants acknowledged that the
messages prompted them to think about chlamydia and show
the text to their friends, while sparking discussions about
sexually transmitted infections. Despite the slight annoyance,
they admitted that text message advertising was a useful mar-
keting tool because “Everyone has a mobile telephone [and]
everyone reads their [texts].” This group also found that radio
and television advertisements were successful in establishing
awareness of the seriousness and prevalence of chlamydia
among their teenaged, media-friendly target audience [21].
In a similar report, the Chlamydia Incidence and Re-Infection
Rates Study recruited sexually active female adolescents by
having research assistants actively recruit all age-eligible
youths who walked into the clinic sites. The research assis-
tants were trained and supervised, so as to provide minimal
disturbance to clinic staff and patients, as well as to differentiate
themselves from clinic staff. Once screened by the research
assistants, the adolescent girls participated in the study by
completing and mailing monthly sexual behavior question-
naires and vaginal swabs at baseline and 6- and 12-month
Figure 1. Disposition plot of review articles found and selected.
T.T. Nguyen et al. / Journal of Adolescent Health 54 (2014) 247e254250intervals. With the completion of the questionnaires and vaginal
swabs, incentives were provided in the form of retail store gift
vouchers and free small gifts (such as tampons and cosmetics).
With each successive completion of vaginal swabs and ques-
tionnaires, the value of the ﬁnancial incentive increased.
Researchers cited face-to-face recruitment as a signiﬁcant reason
for their success with recruitment, as opposed to more conven-
tional methods such as telephone calls, mailed or posted ﬂyers,
or e-mails [36].
Applicable retention strategies (incentives and positive patient-
research staff relationship). Similar to recruitment, retention of
youths in clinical studies tends to be more successful when a
monetary or material incentive is involved. Several groups found
excellent retention (74%e100%) in follow-up visits by offering
compensation to patients who continued participation
[3,4,15,16,18e21,25,27,28,30e32]. Examples of incentives in-
cluded railway passes, movie gift certiﬁcates, school credit, and
retail store gift vouchers to encourage participants to return for
clinic visits or to partake in post-study focus groups
[3,4,15,16,18,24,25,27e30,32,36]. Moreover, monetary and ma-
terial incentives required the fewest staff resources and were the
easiest to acquire or distribute compared with other retention
strategies [3,4,16,19,25,28].
Working with minors, researchers found that success in
clinical research required a mix of trust, conﬁdentiality, and
continuous contact with young patients and their guardians
[18,21,24,26,30,32,37,38]. Earning conﬁdence often included
earning the trust of the communities from which patients were
recruited. This was especially important for groups requiring
particular attention to patient conﬁdentialitydboth in chronic
disorder studies such as human immunodeﬁciency virus (HIV)and social behavior studies including smoking cessation and
injection drug use [18,21,24,32].
Continuous contact between patients, parents or caregivers,
and research staff was the principal tool for the successful
retention in follow-up of patients enrolled in youth studies.
Studies with more mobile populations, such as a group of poor,
highly itinerant adolescent mothers, needed constant tracking to
maintain their study participation. Researchers counteracted
patient loss by actively acquiring alternative contact numbers
from friends, relatives, and neighbors to trace thewhereabouts of
the wandering adolescent mothers [29]. Constant communica-
tion and frequent appointment reminders from the research staff
before each visit improved follow-up attendance, particularly in
social behavior studies of risk reduction for alcoholism, diabetes,
and HIV infection [3,15,27,30,31]. The SEARCH for Diabetes in
Youth Study group acquired multiple addresses and contact
numbers from participants to ensure that study introductory
letters and follow-up calls to parents were received [4]. Two
groups in particular used stringent requirements for updating
contact information to ensure continued contact. In an alcohol
prevention program, the project staff updated addresses every
2 months, and all parents or guardians were contacted by phone
to verify addresses. Students’ teachers took part in reminding
students, and letters were mailed to parents or guardians 1 week
before upcoming data collection events [31]. In an online HIV
prevention intervention, research staff required eligible youth to
provide detailed contact information, including their name,
address, and two telephone numbers, and to create a study
identiﬁcation and password, which required the veriﬁcation of a
valid e-mail address [15].
Because establishing a sense of trust with patients and
guardians is crucial for successful clinical trials involving
Table 2
Successful and applicable recruitment and retention strategies
Strategy Cohort Condition Intervention Reference
Recruitment strategy
Incentives (gift certiﬁcates, cash or checks,
prepaid cellular phones, and calling cards)
Adolescents and
young adults
ages 8e26 years
Chronic disorders (e.g., HIV,
sickle cell disease) and
social behavior studies
Behavioral interventions to promote smoking
cessation and improve management of HIV,
sickle cell, and type 1 diabetes care; health
prevention programs to reduce risk factors
for alcohol abuse, habitual smoking, type 2
diabetes, and HIV infection
[3,4,15,18,24,26e29]
Advertising (online one-click advertisement
banners; coupon-based peer recruitment;
text message advertisements)
Youth ages
15e30 years
Individuals at risk for HIV
infection, active injection
drug users, and young
people at risk for
chlamydia infection
Testing the efﬁcacy of an online HIV-prevention
intervention called “Keep It Real,” preventing
HIV and hepatitis C virus infection among
injection drug users, and investigating the
impact of a multimedia chlamydia campaign
to promote safe sexual behaviors in Australian
youth
[14,17,20]
Retention strategies
Incentives (railway passes, movie gift
certiﬁcates, school credit, or free food)
Adolescents and
young adults
ages 8e30 years
Chronic disorders (e.g., HIV,
sickle cell disease) and
social behavior studies
Behavioral interventions to promote smoking
cessation and improve management of HIV,
sickle cell, and type 1 diabetes care, health
prevention programs to reduce risk factors for
alcohol abuse, type 2 diabetes, and HIV infection
[3,4,14,15,17,19,20,24,26e31]
Trust/conﬁdentiality (required patient
conﬁdentiality for nondisclosure of
HIVepositive status, secret smoking
behaviors, and covert injection drug use)
Adolescents and
young adults
ages 12e30 years
Individuals with positive
HIV infection, smoking
behaviors, and active
injection drug use
Behavioral interventions to improve HIV
management, promote smoking cessation, and
reduce injection and sexual risk behaviors of
active injection drug users
[17,20,23,31,36]
Continuous contact and communication
(acquisition of multiple addresses and
at least two telephone numbers; address
cards updated every 2 months and addresses
veriﬁed by phone with parents/guardians;
constant tracking of patients’ whereabouts
via acquiring alternative contact numbers
from friends, relatives, and neighbors;
mandatory veriﬁcation of valid e-mail
addresses; and constant communication
with frequent appointment reminders)
Youth <25 years Youth diagnosed with type
1 or 2 diabetes; mobile
adolescent mothers that
were largely Hispanic
and only Spanish speaking;
individuals at risk for
alcohol abuse, habitual
smoking, type 2 diabetes,
and HIV infection
Epidemiological study to estimate the prevalence
and incidence of diabetes in children and youth;
longitudinal study characterizing the effect of
young mothers’ interactions with their babies on
the child’s emotional and behavioral development;
behavioral intervention to improve management
of type 1 diabetes care; health prevention programs
to reduce risk factors for alcohol abuse, habitual
smoking, type 2 diabetes, and HIV infection
[3,4,14,25,26,28e30,36,37]
HIV ¼ human immunodeﬁciency virus.
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Figure 2. Four subgroups of pediatric type 2 diabetes.
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recruiting the entire family. Adolescents with type 2 diabetes
are likely to have parents and other relatives with type 2 dia-
betes, who may have already established a relationship with a
medical provider. This suggestion is analogous to current
recruitment strategies in childhood obesity trials, which focus
more on the parents, rather than exclusively on the child [39].
However, in youths with type 2 diabetes, a family-centered
approach may be more difﬁcult because most live with only
one parent, or none [13]. The cost of transportation and pro-
viders’ work schedules also need to be considered. Thus, facili-
tating participation in clinical trials by seeing patients in the
evening after school or work and on weekends appears prom-
ising but has not been thoroughly tested. A transition care
program in Australia improved diabetes control, increased clinic
attendance, and reduced emergency hospital admission rates
for diabetic ketoacidosis among young adults with type 1 dia-
betes by providing access to appointment coordinators, diabetes
educators, and after-hours phone support [40].
Strategies with limited applicability to adolescents with type 2
diabetes. School-based recruitment efforts are typically effective
for youth studies other than those regarding type 2 diabetes.
Although middle and high school students are commonly
affected by obesity and may frequently exhibit high-risk behav-
iors, even in a population with a particularly high prevalence of
type 2 diabetes, such the Navajo, few cases were ascertained in
school-based screening programs and thus, even fewer cases are
expected to be enrolled in schools with mixed racial and ethnic
populations [41]. We found that contacting 64 school nurses and
sending out ﬂyers to 128 middle and high schools resulted in no
referrals.
However, for clinical trials studying adolescents before the
onset of overt type 2 diabetes, schoolsmay provide an opportunity
in which word of mouth and peer-to-peer recruitment help
establish trust between investigators and potential participants[3,16,20,30]. To spark interest and generate awareness, contests,
giveaways, and in-class presentations during school have been
used [42,43]. In the HEALTHY study (middle-school based primary
prevention trial of type 2 diabetes), clinicians actively participated
in the community in what they termed “pre-recruitment” activ-
ities, including school orientations and community meetings.
They increased enrollment by engaging families and earning their
trust, while ensuring that both parents or caregivers and students
thoroughly understood the study purpose and easily recognized
the members of the research staff [3,17]. In addition, they found
that having a continuous rolling recruitment period allowed
enrolled students to share their initial experiences and thus
encourage peers still considering participation [3,16].
In a recent campaign to study HIV prevention among young
black men, the Colorado School of Public Health formed a part-
nership with MEE Productions, a communications research and
marketing ﬁrm with strong ties to community-based organiza-
tions (CBOs) across the country. An important goal was to explain
why the research topic was of particular importance to the
community. By aligning itself with the CBOs, the research team
found increased access to African-American youth and estab-
lished trust with participants, who associated the study with the
CBOs, and thus were more likely to enroll and to continue
participation [43].
Discussion
Successful recruitment and retention in clinical trials in youth
with type 2 diabetes is challenging. One reason, although by far
not the most important, is the relatively low incidence: In the
U.S., approximately 1.8 million adults are diagnosed with type 2
diabetes annually, contrasted by only several thousand new
pediatric patients [42]. The relatively small number of new cases
limits the pool of candidates eligible for participation in clinical
trials [9e11,13,43,44]. However, many clinical studies are con-
ducted in young patients with conditions rarer than type 2 dia-
betes. Thus, type 2 diabetes in youth represents a speciﬁc
constellation of taxing factors, such as being a relatively silent
but serious medical condition, occurring more frequently in less
socioeconomically privileged youths with co-morbid conditions
such as obesity, and occurring in youths with suboptimal role
models in their families.
Recruitment of minorities poses distinctive difﬁculties. Pre-
vious research abuse, especially in the African-American com-
munity, and lack of trustdfor example, in the Hispanic
community regarding reporting of immigration statusdneed to
be recognized as hurdles to be overcome by gaining their trust.
Ethical questions arise in the context of low-income family
backgrounds irrespective of ethnicity, owing to both lack of
health insurance and access to primary care resources. Thus,
participation in a clinical trial might represent the only way of
receiving medical care. Questions also arise at the end of clinical
trials when the relationship between researcher and participant
inevitably terminates, and potentially poses a dilemma if the
study participant has come to view the researcher as a primary
care provider. A recent publication presented recruitment and
retention results according to race in The Environmental De-
terminants of Diabetes in the Young (TEDDY) Study, a multi-
center project designed to identify environmental factors that
contribute to type 1 diabetes. In general, Hispanic and African-
American participants were more than twice as likely to be
excluded at screening as their non-Hispanic white counterparts
T.T. Nguyen et al. / Journal of Adolescent Health 54 (2014) 247e254 253because of incorrect contact information. Socioeconomic pat-
terns discussed in this study suggested that higher mobility, less
education, and younger age of the mothers was associated with
higher rates of exclusion. Other reasons cited for the prominent
differences in enrollment were the time demands of the protocol,
unstable living conditions, and communication barriers resulting
from language differences and comprehension [44].
As mentioned above, monetary compensation represents one
of the incentives most commonly used in clinical research to
facilitate recruitment and retention. However, there is a wide
range in standards of research compensation that can vary for
the same procedure by several orders of magnitude [45].
Inherent ethical, regulatory, and economic issues become even
more relevant in the case of vulnerable subjects such as children,
especially when belonging to lower socioeconomic strata. In
pediatric studies, monetary compensation may be given to par-
ents who take it on behalf of the minor subject or to the minors
themselves [45]. Whoever the material recipient is, few pro-
visions are provided by institutional review boards to ensure that
the money will be used in the best interests of the child.
It is generally accepted that the amount paid to a research
participant should be adequate to provide a fair incentive for
participation as well as to offer reimbursement for time and
inconvenience. Calculating the amount of reimbursement for an
adult might be simple; in the case of a minor, this exercise be-
comes more difﬁcult because of the lack of a reference system
represented by earnings.
It is also generally accepted that the total amount offered
should not be so high as to represent an undue enticement.
A thought-provoking question is whether there should be an
upper limit to the amount of monetary compensation in the ﬁrst
place, or whether the ﬁnal compensation, the “ﬁnal price,”
should not be limited a priori, but should simply be determined
by the intercept between demand and supply, as is typically the
case in a free market society. But how much is too much? We
raise the question of whether an upper limit of compensation
should be based on the average participant, reﬂecting an ideal,
weighted average of each potential participant, or whether it
should be determined based on the speciﬁc income and living
expenses of the prospective participants and their families. This
exercise in normalizing the amount of compensation based on
location and socioeconomic status of the participant has not
been previously implemented, to the best of our knowledge. In
theory, a randomized controlled study could be designed in
which participants belonging to communities similar in income
and epidemiological proﬁle are randomized to receiving a
normal reimbursement versus an amount several fold higher for
the same research protocol. The null hypothesis would be that
recruitment and retention are not different between the two
groups of communities.
The issues discussed above are not exclusively relevant and
applicable to pediatric research in the ﬁeld of type 2 diabetes;
they are general issues inherent to the nature of clinical research.
Most clinicians and physician-investigators will agree that
adolescents with type 2 diabetes frequently have problems with
routine patient care and compliance with diet and medications,
and are reluctant to participate in clinical trials. Many of these
youths are characterized by the overlap of four uniquely chal-
lenging factors: adolescence, minority, type 2 diabetes, and
obesity (Figure 2). Most clinical trials in type 2 diabetes in youth
focus on beta cell function and blood glucose control, but these
outcomes are often not perceived as highly relevant by thesepatients, who frequently identify obesity as the primary problem.
In fact, participation in a clinical trial might even lead to weight
gain, for example, due to insulin administration. In addition,
obesity is not seen primarily as a health concern by these
youngsters, but as an obstacle to ﬁtting a certain body image
ideal, thus affecting social acceptance and self-esteem. Therefore,
they may not identify health care providers as helpful resources
to combat these issues.
Core components of successful recruitment into clinical trials
involving adolescents are established trust between researchers
and the participants and their families, monetary incentives, and
creative advertising. More time and effort need to be spent
investing adolescent participants in the existent beneﬁts of
participation in the study, such as material incentives, increased
health rewards, and societal beneﬁts, while simultaneously
making participation inexpensive (e.g., with reimbursement of
transportation costs) and convenient (e.g., with evening or
weekend clinic visits or home visits) for the entire family.
Major challenges for researchers studying type 2 diabetes in
youth are highlighted by the fact that only six of the 16 inter-
ventional trials initiated in this population have been success-
fully completed to date, and only ﬁve prospective, interventional
studies have published results [46]. Although the fate of the
incomplete studies is not clear, many may have been suspended
because of slow recruitment. By comparing results of many large
studies in adults (e.g., United Kingdom Prospective Diabetes
Study [UKPDS]) with the only existing large study in adolescents,
the TODAY trial, we learned that interventions that work for
adults with type 2 diabetes may not be effective in youths with
regard to either medical treatment (e.g., metformin) or lifestyle
changes. Thus, informative clinical research is urgently needed
and steps need to be taken to make this research possible. This
may be achieved by learning more about motivation in adoles-
cents with type 2 diabetes, by prospectively collecting data on
patient recruitment and retention in future studies, and by
providing them and their families and caregivers with tangible
beneﬁts and practical help when participating in clinical trials.Acknowledgments
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